Skip to main content
. 2017 Jan 31;40(4):255–261. doi: 10.1002/clc.22634

Table 1.

Overview of cardiovascular structures being affected after RT

Tissue Involved Diagnostic Consideration Time of Presentation After RT Cardiac Evaluation
Pericardium Acute pericarditis Days to weeks TTE
Chronic effusion Weeks to months TTE
Constrictive pericarditis Years TTE, MRI, right‐sided catheterization
Vascular tree Premature CAD Years CT, SPECT, catheterization, TTE (stress), risk factors
MI Months to years Catheterization
Asymptomatic CAD Years CT, SPECT, catheterization, TTE (stress), risk factors
Aortic arch calcification Years CT, MRI
Carotid stenosis Years Perfusion imaging, MRI, risk factors
TIA/stroke Months to years Perfusion imaging, MRI, risk factors
PVD Months to years Perfusion imaging, CT‐flow
Endocardium Valvular disease Years Echo (stress), TEE
Myocardium Myocarditis Weeks to months Echo, MRI, biomarkers
Cardiomyopathy Months to years TTE
Chronic HF Years TTE
Diastolic dysfunction Years TTE
Conduction system Heart block Months to years ECG, Holter

Abbreviations: CAD, coronary artery disease; CT, computed tomography; ECG, electrocardiogram; Echo, echocardiography; HF, heart failure; MI, myocardial infarction; MRI, magnetic resonance imaging; PVD, peripheral vascular disease; RT, radiotherapy; SPECT, single‐photon emission computed tomography; TEE, transesophageal echocardiography; TIA, transient ischemic attack; TTE, transthoracic echocardiography.